about
Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flowThe status of contemporary image-guided modalities in oncologic surgeryCombination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancerCanine prostate cancer cell line (Probasco) produces osteoblastic metastases in vivoMicrotubule inhibitor-based antibody-drug conjugates for cancer therapy.Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs.Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA).Development of prostate specific membrane antigen targeted ultrasound microbubbles using bioorthogonal chemistry.The dog prostate cancer (DPC-1) model: a reliable tool for molecular imaging of prostate tumors and metastases.Expression, purification and identification of an immunogenic fragment in the ectodomain of prostate-specific membrane antigenA Novel Prostate-Specific Membrane-Antigen (PSMA) Targeted Micelle-Encapsulating Wogonin Inhibits Prostate Cancer Cell Proliferation via Inducing Intrinsic Apoptotic Pathway.18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients.Molecular imaging of urogenital diseases.68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience.Pharmacokinetic and Biodistribution Assessment of a Near Infrared-Labeled PSMA-Specific Small Molecule in Tumor-Bearing Mice.Individualized image-based lymph node irradiation for prostate cancer.Molecular and functional imaging for detection of lymph node metastases in prostate cancer.Zirconium-89 labeled antibodies: a new tool for molecular imaging in cancer patients.The clinical and therapeutic uses of MDM2 and PSMA and their potential interaction in aggressive cancers.PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer.In vivo imaging of prostate cancer using an anti-PSMA scFv fragment as a probe.PSMA-specific theranostic nanoplex for combination of TRAIL gene and 5-FC prodrug therapy of prostate cancer.The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological diseaseIR-780 dye for near-infrared fluorescence imaging in prostate cancer.PSMA-targeting iron oxide magnetic nanoparticles enhance MRI of preclinical prostate cancer.Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists.Near‑infrared fluorescence imaging of prostate cancer using heptamethine carbocyanine dyes.The clinical role of multimodality imaging in the detection of prostate cancer recurrence after radical prostatectomy and radiation therapy: past, present, and futurePreparation and evaluation of carborane-derived inhibitors of prostate specific membrane antigen (PSMA).N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype.Heterobivalent agents targeting PSMA and integrin-αvβ3.Novel Monoclonal Antibodies Recognizing Human Prostate-Specific Membrane Antigen (PSMA) as Research and Theranostic Tools.Lymph node imaging in initial staging of prostate cancer: An overview and update.Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer.Development of a Single Vial Kit Solution for Radiolabeling of 68Ga-DKFZ-PSMA-11 and Its Performance in Prostate Cancer Patients.(68)Ga-PSMA-11 dynamic PET/CT imaging in biochemical relapse of prostate cancer.Writing PET into existence.[Vertebral metastases of urogenital carcinomas: Diagnosis and conservative therapy].
P2860
Q27334142-76E161BC-D5F7-4463-BA98-0CAF96AA8EFAQ30394594-FD7F219F-94FE-45E0-B844-2150501EB04FQ30557008-921CD8ED-4CC8-49E1-AB5F-8798402E7920Q34438300-C8D67F2D-6697-4CD0-8A47-692826684477Q34655256-930D27F6-0204-43B1-8DD5-C5E4DA86BB9FQ35092050-B6F14FCB-E0EC-4CBA-ACAC-BE1E13C68C49Q35282416-93D52D66-9DCA-4E27-AFA3-ECE0EE9A0390Q36363280-5C7CBCCF-308A-4078-A5CD-BAE7F2337C1EQ36415375-7D14AAB0-9219-4065-8323-CA5DF71CB17EQ36640007-22B36C6D-511C-4DF2-A360-01C0DF3243D3Q36939199-1C31BC76-9EB0-4059-A4CE-0274A2FA4D35Q37214513-C06E2278-F890-42C3-A2B3-B021E6C3FDBFQ37550399-C1A22947-6DE6-48A3-B270-290FFF57B9AEQ37554235-8ADC5878-8462-461E-AD7D-7249067DD9BAQ37719087-9F8897B4-B678-4961-8EF8-525B9C212F1AQ38109812-451CB871-0576-4F7B-8A18-451375E35FB9Q38119113-75E8A855-0BA9-42EB-BFE1-4ADC6236709EQ38225877-8F92346E-1DF8-46CD-98BB-B9681F6CA9A8Q38637803-F8D27B50-AFA3-44F3-8DF1-08822793F643Q38779853-4C55F7C6-5303-4966-92A8-B6A437AE6666Q38784721-DAB48781-7801-4931-8B05-89AD3170161EQ38808957-5E0FD1CD-8556-4A95-9616-C664B2BB1E82Q38831232-4D8F3802-74C1-4F42-BE1F-5C04BCFC551AQ38909135-84AD9DB9-C949-47DD-90D5-85BEF4BFC810Q38939408-09114DB0-650B-40F2-A187-A18FE3BEB7D6Q38941339-7EBC94A0-1881-4E23-9D67-8124F9D92476Q38944074-E74FF7C3-D422-4949-A27A-7AF569AAC2D2Q38956835-425EB731-C890-43E5-B875-DE4AE2CEBFEDQ39028837-84637BB8-F0C3-4370-99F5-DA19EF2CAEAAQ39062377-C5E0A36B-6311-4253-9B5C-58872D4F04BCQ42751344-FEAD6C70-5345-4BD9-8700-0BC50EA8B121Q46411145-BD1DE182-2081-497E-B8C4-79BB251F688EQ47157403-1CB37F68-E4C3-4A00-B4BF-843C779289DFQ51743830-3B6998D0-0B8F-4644-8584-BED2E2024CC3Q51803631-65C3FE9F-083E-49F7-A4F4-26289E6367CCQ52985772-C376E2C9-4124-44B3-94C2-798C10F49EBEQ53094162-18ECDE3A-AD0E-468C-8119-F9D4059313CAQ53322716-4BE578F0-BFFB-488E-BF76-21D43F103016
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Prostate-specific membrane antigen-based imaging.
@en
type
label
Prostate-specific membrane antigen-based imaging.
@en
prefLabel
Prostate-specific membrane antigen-based imaging.
@en
P2093
P2860
P1433
P1476
Prostate-specific membrane antigen-based imaging.
@en
P2093
Alok Anand
Naveed H Akhtar
Scott T Tagawa
Shankar Vallabhajosula
P2860
P304
P356
10.1016/J.UROLONC.2012.04.016
P577
2012-05-31T00:00:00Z